| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.09 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.46 | 0.1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |